Portage Biotech Inc
PRTG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.87M
Close$
$0.24
96.4% downside
Current Fair Value
96.4% downsideOvervalued by 96.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $8.87 Million |
|---|---|
| Enterprise Value | $7.20 Million |
| Earnings per Share | $-4.18 |
| Beta | 0.64 |
| Outstanding Shares | 1,303,000 |
Return
| Return on Equity | 5501.63% |
|---|---|
| Return on Assets | -304.13% |
| Return on Invested Capital | -659.38% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | -6.81 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.97 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
February 26, 2026
EPS Estimate
$-0.35
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Portage Biotech Inc
22 employees
CEO: Brittany Kaiser
Portage Biotech Inc. is a unique entity in the world of biotechnology, catalyzing R&D to produce more quality clinical programs and maximize potential returns.